Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Amiodarone, Lidocaine or Neither for Out-Of-Hospital Cardiac Arrest Due to Ventricular Fibrillation (VF) or Ventricular Tachycardia (VT).

Next Previous
Search
Trial Profile

Amiodarone, Lidocaine or Neither for Out-Of-Hospital Cardiac Arrest Due to Ventricular Fibrillation (VF) or Ventricular Tachycardia (VT).

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 30 Dec 2021

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Amiodarone (Primary) ; Lidocaine
  • Indications Heart arrest; Ventricular fibrillation; Ventricular tachycardia
  • Focus Therapeutic Use
  • Acronyms ALPS

    • Most Recent Events

    • 15 Nov 2021 Results assessing utilize machine learning to construct predictive models of neurologically favorable survival in OHCA patients receiving standard ACLS and extracorporeal cardiopulmonary resuscitation (ECPR) presented at the American Heart Association Scientific Sessions 2021
    • 13 Sep 2017 Results of a pre-specified analysis in patients with non-shockable OHCA (n=1063) published in the Circulation
    • 29 Jan 2017 Status changed from active, no longer recruiting to completed.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top